Formulary Monographs [VIDAGLIPTIN|METFORMIN, 682005]
|
|
VILDAGLIPTIN | METFORMIN
|
|
|
|
|
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
Type 2 diabetes mellitus as monotherapy (if metformin inappropriate), or in combination with other antidiabetic drugs (including insulin) if existing treatment fails to achieve adequate glycaemic control.
|
|
|
Asthenia, dizziness, headache, nausea;, peripheral oedema, tremor.
|
|
|
1 tablet twice daily based on patient’s current metformin dose.
|
|
|
|
|
|
|
|
|
|
|
|
|